Regression/eradication of gliomas in mice by a systemically-deliverable ATF5 dominant-negative peptide.
Cates CC, Arias AD, Nakayama Wong LS, Lamé MW, Sidorov M, Cayanan G, Rowland DJ, Fung J, Karpel-Massler G, Siegelin MD, Greene LA, Angelastro JM.
Cates CC, et al. Among authors: angelastro jm.
Oncotarget. 2016 Mar 15;7(11):12718-30. doi: 10.18632/oncotarget.7212.
Oncotarget. 2016.
PMID: 26863637
Free PMC article.